AU2002239417A1 - Diagnostic and therapeutic compositions and methods related to anaphylatoxin c3a receptor - Google Patents
Diagnostic and therapeutic compositions and methods related to anaphylatoxin c3a receptorInfo
- Publication number
- AU2002239417A1 AU2002239417A1 AU2002239417A AU3941702A AU2002239417A1 AU 2002239417 A1 AU2002239417 A1 AU 2002239417A1 AU 2002239417 A AU2002239417 A AU 2002239417A AU 3941702 A AU3941702 A AU 3941702A AU 2002239417 A1 AU2002239417 A1 AU 2002239417A1
- Authority
- AU
- Australia
- Prior art keywords
- anaphylatoxin
- diagnostic
- receptor
- therapeutic compositions
- methods related
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Psychology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25025100P | 2000-11-29 | 2000-11-29 | |
US60/250,251 | 2000-11-29 | ||
US25045200P | 2000-11-30 | 2000-11-30 | |
US60/250,452 | 2000-11-30 | ||
US33003601P | 2001-10-17 | 2001-10-17 | |
US60/330,036 | 2001-10-17 | ||
PCT/US2001/045220 WO2002044737A2 (en) | 2000-11-29 | 2001-11-29 | Diagnostic and therapeutic compositions and methods related to anaphylatoxin c3a receptor |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002239417A1 true AU2002239417A1 (en) | 2002-06-11 |
Family
ID=27400298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002239417A Abandoned AU2002239417A1 (en) | 2000-11-29 | 2001-11-29 | Diagnostic and therapeutic compositions and methods related to anaphylatoxin c3a receptor |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002239417A1 (en) |
WO (1) | WO2002044737A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002239417A1 (en) * | 2000-11-29 | 2002-06-11 | Lifespan Biosciences, Inc. | Diagnostic and therapeutic compositions and methods related to anaphylatoxin c3a receptor |
WO2004082566A2 (en) * | 2003-03-17 | 2004-09-30 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with complement component 3a receptor 1 (c3ar1) |
EP1782072A2 (en) * | 2004-04-15 | 2007-05-09 | Reglia AB | Materials and methods for screening modulators of neural regneration |
JPWO2011071136A1 (en) | 2009-12-11 | 2013-04-22 | アステラス製薬株式会社 | Fibromyalgia treatment |
GB201619637D0 (en) * | 2016-11-21 | 2017-01-04 | Pekna Marcela And Pekny Milos And Stokowska Anna | C3a receptor agonists |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1087700A (en) * | 1996-06-17 | 1998-04-07 | Smithkline Beecham Corp | Treatment and screening using c3a receptor and c3a |
US5989592A (en) * | 1996-10-03 | 1999-11-23 | Coastside Bio Resources | Inhibition of complement pathway by sea cucumber fractions |
JP2001517648A (en) * | 1997-09-23 | 2001-10-09 | スミスクライン・ビーチャム・コーポレイション | C3A receptor ligand |
AU2002239417A1 (en) * | 2000-11-29 | 2002-06-11 | Lifespan Biosciences, Inc. | Diagnostic and therapeutic compositions and methods related to anaphylatoxin c3a receptor |
-
2001
- 2001-11-29 AU AU2002239417A patent/AU2002239417A1/en not_active Abandoned
- 2001-11-29 WO PCT/US2001/045220 patent/WO2002044737A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002044737A2 (en) | 2002-06-06 |
WO2002044737A3 (en) | 2003-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4835001A (en) | Antibodies to human cd154 | |
AU6118001A (en) | Combination therapeutic compositions and methods of use | |
HK1061403A1 (en) | ANTIBODIES TO HUMAN IL-1ß | |
HUP0500983A2 (en) | Methanesulphonamido-benzofuran, preparation method and use thereof as synthesis intermediate | |
IL158107A0 (en) | Human papillomaviruses vaccine | |
AU1328502A (en) | Novel targeted compositions for diagnostic and therapeutic use | |
AU2001233081A1 (en) | Composition for treatment of stress | |
EP1545599A4 (en) | Immunogenic compositions and diagnostic and therapeutic uses thereof | |
AU2001279540A1 (en) | Dental splint | |
GB0002386D0 (en) | Therapeutic composition | |
HUP0303731A3 (en) | Sulfonylguanidines and their use for preparation of pharmaceutical compositions | |
HUP0301317A3 (en) | Use of neuroprotective 7-beta-hydroxysteroids for preparation of pharmaceutical compositions | |
HUP0104963A3 (en) | Compositions for the treatment of skin diseases | |
AU2001232866A1 (en) | Skin care compositions | |
AU2002239417A1 (en) | Diagnostic and therapeutic compositions and methods related to anaphylatoxin c3a receptor | |
GB9928535D0 (en) | Use of sugar compositions | |
GB0009609D0 (en) | Therapeutic compositions | |
GB0315266D0 (en) | Novel galactooligosaccharide composition and the preparation thereof | |
GB0030857D0 (en) | Therapeutic compositions | |
HUP0301134A3 (en) | Use of 7-hydroxyepiandrosterone having neuroprotective activity for preparing pharmaceutical compositions | |
GB0009607D0 (en) | Medical compositions | |
AU2001255168A1 (en) | Compositions and methods for the treatment of immune related diseases | |
AU2001253219A1 (en) | Composition for treatment of autoimmune disease | |
GB2420709B (en) | Skin preparation composition | |
HUP0400007A2 (en) | Use of an alkanoyl-l-carnitine for the preparation of pharmaceutical composition to treat anhedonia |